Mayo Clinic Advances Personalized Care for Meningioma Patients with New Review
Mayo Clinic researchers have published a comprehensive review in Nature Reviews Clinical Oncology, focusing on personalized care for meningioma, the most common primary brain tumor. The review emphasizes a shift from traditional treatment methods, which relied heavily on tumor appearance under a microscope, to a more integrated approach using molecular, imaging, and clinical data. This new methodology aims to improve diagnosis, prognosis, and treatment outcomes. Key advancements include the use of new molecular classification systems for better prediction of tumor growth or recurrence, advanced imaging techniques like PET/MRI for earlier detection of residual or returning tumors, and innovations in surgical and radiotherapy techniques that are less invasive and safer. These developments are part of a broader move towards precision medicine, allowing for more tailored treatment plans that can improve patient outcomes and quality of life. 
